Hendrix S G, Patterson R, Zeiss C R, Suszko I M
J Clin Immunol. 1982 Jan;2(1):10-4. doi: 10.1007/BF00915972.
The antigenicity of polymerized grass (PG) and monomer grass (MG) was studied. As compared with MG, PG produces a similar immunologic response in rabbits as demonstrated by a tanned red blood cell (TRBC) passive hemagglutination assay or by total serum binding of perennial rye grass Group I antigens (RGGI). Six patients with allergic rhinitis sensitive to several grass pollens received an average of 60,000 protein nitrogen units (PNU) or PG. The initial dose was 100 PNU ans a maintenance dosage of 8500 PNU was obtained after six injections without systemic reactions in any of the patients. Serum binding of RGGI increased significantly in the PG-treated patients and this increase was quantitatively similar to that measured in a second group of six atopic patients previously treated for 1 year with a total of 100,000 PNU of a standard grass extract mixture. PG, like polymerized ragweed (PRW), has a reduced allergenicity while retaining immunogenicity. These data suggest that PG as compared to standard aqueous grass extract mixtures represents an improved form of immunotherapy for the atopic patients.
研究了聚合草(PG)和单体草(MG)的抗原性。与MG相比,PG在兔子身上产生了类似的免疫反应,这通过鞣酸红细胞(TRBC)被动血凝试验或多年生黑麦草I组抗原(RGGI)的总血清结合来证明。六名对几种草花粉过敏的变应性鼻炎患者平均接受了60,000蛋白氮单位(PNU)的PG。初始剂量为100 PNU,六次注射后获得了8500 PNU的维持剂量,所有患者均无全身反应。PG治疗患者中RGGI的血清结合显著增加,这种增加在数量上与先前用总共100,000 PNU标准草提取物混合物治疗1年的另一组六名特应性患者中测得的增加相似。PG与聚合豚草(PRW)一样,致敏性降低而保留免疫原性。这些数据表明,与标准水性草提取物混合物相比,PG是特应性患者免疫疗法的一种改进形式。